Brain Behav Immun 55:8292 Shan Y, Tan S, Lin Y, Liao S, Zhang B, Chen X, Wang J, Deng Z, Zeng Q, Zhang L, Wang Y, Hu XQ, Qiu W, Peng L, Lu ZQ (2019) The glucagon-like peptide-1 receptor agonist reduces inflammation and blood-brain barrier breakdown in an astrocyte-dependent manner in experimental stroke
One randomized controlled trial of exenatide in patients with obesity and alcohol use disorder found trends toward reduced drinking, though results did not reach statistical significance in the primary outcome
Potinital GLP-1 use to pevent the clinical progression of PAD in individuals with type 2 diabetes
An IV infusion ensures these compounds are available at therapeutic levels without relying on the digestive system for absorption
Severe hypoglycemia below 40 mg/dL can produce loss of consciousness